Kidney transplantation
ProcedureParticipants in this study will have had a kidney transplant
NCT Number: NCT00308802
The purpose of this study is to test noninvasive methods to monitor the health and condition of new kidneys in people who have received kidney transplants.
Looking for future studies?
Notify MeAll sexes
Observational
Children's Hospital of Winnipeg, Winnipeg, Manitoba, Canada
Innovations in kidney transplantation have improved short-term outcomes for transplant patients. However, organ rejection remains as an important threat to the long-term survival of the transplanted organ. If clinicians could better monitor the condition of the organ after transplantation, they may be able to improve the chance of graft survival. Noninvasive ways to monitor the condition of the transplanted organ need to be developed and tested. This observational study will investigate whether certain blood and urine tests are useful in monitoring the health of transplanted kidneys.
This trial will involve 14 post-transplant study visits over the course of 2 years. A physical exam, medication history, adverse events assessment, and blood and urine collection will occur at all visits. Kidney biopsies will occur at study entry prior to transplantation and at Month 6, in adult participants only. Protocol biopsies are optional in the pediatric substudy group. Additional visits may be required if organ rejection is suspected.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in this study will have had a kidney transplant
National Institute of Allergy and Infectious Diseases (NIAID)
Nih
Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01380847
Chronic Disease, Disease Attributes
Paris, France
View Trial DetailsNCT00531921
Behavior, Cardiovascular Diseases
Chicago, Illinois, United States
View Trial DetailsNCT01143532
Chronic Disease, Disease Attributes
Bethesda, Maryland, United States
View Trial DetailsNCT00246129
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
London, United Kingdom
View Trial Details